Tags: breast | cancer | drug | europe | japan

Breast Cancer Drug Gets Approval for Use in Europe, Japan

Friday, 20 Sep 2013 05:21 PM

By Robin Farmer

  Comment  |
   Contact Us  |
|  A   A  
  Copy Shortlink
Roche’s new breast cancer drug designed for patients with late-stage disease won approval for use in Japan and Europe on Friday.

Reuters reported that the backing in Japan and Europe of Kadcyla, also known as T-DMI, follows U.S. approval of the drug earlier this year.

Urgent: Should Obamacare be Repealed? Vote Here Now

Designed for patients whose cancer cells contain increased amounts of a protein known as HER2, Kadcyla slows cancer cell growth and preserves quality of life, according to a Roche media release.

There is currently no cure for metastatic breast cancer.

“Kadcyla’s highly effective, targeted mode of action offers patients a chance to extend their lives with fewer of the side effects commonly experienced with chemotherapy,” said Hal Barron, M.D., Roche’s Chief Medical Officer and Head, Global Product Development, in the media release. “We hope that this new medicine is soon available to patients with metastatic breast cancer in Europe.”

Patients in a clinical study who were treated with Kadcyla had their life expectancy extended to more than 18 months overall, according to the company.

The drug is pricey. According to BioWorld, a monthly course of Kadcyla costs $9,800.

Roche licenses technology for Kadcyla under an agreement with ImmunoGen Inc. Reuters reported that ImmunoGen gets a $5 million milestone payment from Roche following the Japanese approval.

Urgent: Will Obamacare Hurt Your Wallet? Vote Here Now

Related stories:

Osteoporosis Drug Halts Breast Tumors, Duke Study Finds

Breast Cancer-Prone Women Urged to Take Preventive Drugs

© 2014 Newsmax. All rights reserved.

  Comment  |
   Contact Us  |
  Copy Shortlink
Send me more news as it happens.
Get me on The Wire
Send me more news as it happens.
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
Zip Code:
Privacy: We never share your email.
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
You May Also Like

Tapeworm in Brain of Man for 4 Years Removed by Surgeons

Saturday, 22 Nov 2014 17:33 PM

A tapeworm that not only lived in a man's brain for four years but traveled from one side of the brain to the other has  . . .

Window Washer's 11-Story Fall Ends Atop Car - He Survived!

Saturday, 22 Nov 2014 17:14 PM

A window washer survived with critical injuries after falling 11 stories from the roof of a San Francisco bank building  . . .

Georgia O'Keefe $44 Million Painting Most for Woman Artist

Saturday, 22 Nov 2014 16:49 PM

A new world auction record for women artists was set when a painting by late American artist Georgia O'Keeffe sold for m . . .

Top Stories

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

America's News Page
©  Newsmax Media, Inc.
All Rights Reserved